tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LIVN Stock Latest News

LivaNova price target raised to $67 from $58 at Barclays
The FlyLivaNova price target raised to $67 from $58 at Barclays
4d ago
LIVN
LivaNova price target raised to $66 from $56 at Goldman Sachs
PremiumThe Fly
LivaNova price target raised to $66 from $56 at Goldman Sachs
4d ago
LIVN
LivaNova price target raised to $70 from $65 at Stifel
PremiumThe Fly
LivaNova price target raised to $70 from $65 at Stifel
6d ago
LIVN
KeyBanc starts LivaNova at Overweight on estimate upside potential
PremiumThe Fly
KeyBanc starts LivaNova at Overweight on estimate upside potential
26d ago
LIVN
LivaNova initiated with an Overweight at KeyBanc
PremiumThe Fly
LivaNova initiated with an Overweight at KeyBanc
26d ago
LIVN
LivaNova price target raised to $72 from $70 at Mizuho
PremiumThe FlyLivaNova price target raised to $72 from $70 at Mizuho
27d ago
LIVN
LivaNova price target raised to $75 from $70 at Baird
Premium
The Fly
LivaNova price target raised to $75 from $70 at Baird
28d ago
LIVN
LivaNova receives increased CMS reimbursement for VNS Therapy
Premium
The Fly
LivaNova receives increased CMS reimbursement for VNS Therapy
2M ago
LIVN
LivaNova price target raised to $70 from $65 at Mizuho
PremiumThe Fly
LivaNova price target raised to $70 from $65 at Mizuho
2M ago
LIVN
LivaNova price target raised to $70 from $63 at Baird
PremiumThe Fly
LivaNova price target raised to $70 from $63 at Baird
2M ago
LIVN
LivaNova’s Strategic Growth Plan and OSA Device Commercialization Justify Buy Rating
PremiumRatings
LivaNova’s Strategic Growth Plan and OSA Device Commercialization Justify Buy Rating
2M ago
LIVN
LivaNova expects OSA business to be break-even by 2029
PremiumThe Fly
LivaNova expects OSA business to be break-even by 2029
2M ago
LIVN
LivaNova introduces 2030 financial targets at Investor Day
PremiumThe FlyLivaNova introduces 2030 financial targets at Investor Day
2M ago
LIVN
LivaNova price target raised to $63 from $61 at Baird
Premium
The Fly
LivaNova price target raised to $63 from $61 at Baird
2M ago
LIVN
LivaNova PLC Reports Strong Q3 2025 Results
Premium
Company Announcements
LivaNova PLC Reports Strong Q3 2025 Results
2M ago
LIVN
LivaNova PLC Reports Strong Q3 Growth Amid Challenges
PremiumCompany Announcements
LivaNova PLC Reports Strong Q3 Growth Amid Challenges
2M ago
LIVN
LivaNova’s Strong Q3 Performance and Growth Prospects Reinforce Buy Rating
PremiumRatings
LivaNova’s Strong Q3 Performance and Growth Prospects Reinforce Buy Rating
2M ago
LIVN
LivaNova reports Q3 adjusted EPS $1.11, consensus 92c
PremiumThe Fly
LivaNova reports Q3 adjusted EPS $1.11, consensus 92c
2M ago
LIVN
LivaNova raises FY25 adjusted EPS view to $3.80-$3.90 from $3.70-$3.80
PremiumThe Fly
LivaNova raises FY25 adjusted EPS view to $3.80-$3.90 from $3.70-$3.80
2M ago
LIVN
LIVN Earnings this Week: How Will it Perform?
PremiumPre-EarningsLIVN Earnings this Week: How Will it Perform?
2M ago
LIVN
LivaNova’s VNS Therapy Study: A Potential Game-Changer for Depression Treatment
Premium
Company Announcements
LivaNova’s VNS Therapy Study: A Potential Game-Changer for Depression Treatment
3M ago
LIVN
LivaNova’s VNS Therapy Study: A Potential Game-Changer for Treatment-Resistant Depression
Premium
Company Announcements
LivaNova’s VNS Therapy Study: A Potential Game-Changer for Treatment-Resistant Depression
3M ago
LIVN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >